Mansel Aylward

Mansel Aylward's AcademicInfluence.com Rankings

Mansel Aylward

Philosophy

#12290

World Rank

#17052

Historical Rank

Logic

#9138

World Rank

#11534

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Mansel Aylward Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Mansel Aylward CB MD DSc FFOM FCRP FLSW is a Welsh public health physician and academic. He was Chief Medical Officer, Medical Director and Chief Scientist at the U.K. Government Department for Work and Pensions.

(See a Problem?)

Mansel Aylward's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Work and common health problems. (2007) (92)
The scientific and conceptual basis of incapacity benefits (2005) (76)
Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. (1984) (74)
The power of belief: psychosocial influences on illness, disability and medicine (2006) (72)
Prioritising pain in policy making: the need for a whole systems perspective. (2008) (54)
Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control. (1980) (49)
Estrogens, plasma tryptophan levels in perimenopausal patients (1976) (49)
Models of sickness and disability: applied to common health problems (2009) (48)
Beliefs about common health problems and work: a qualitative study. (2008) (44)
Long-term study of indomethacin and alclofenac in treatment of rheumatoid arthritis. (1975) (39)
Regional trends in awards of incapacity benefit by cause. (2011) (39)
Inside the fitness for work consultation: a qualitative study. (2009) (37)
A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis. (1975) (35)
Plasma-tryptophan levels in depression. (1973) (35)
Total and free‐plasma tryptophan concentrations in rheumatoid disease (1973) (34)
A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis. (1973) (31)
The cost effectiveness of NHS physiotherapy support for occupational health (OH) services (2012) (30)
A Biopsychosocial Model of Sickness and Disability (2008) (27)
An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients. (1974) (25)
Managing long-term worklessness in primary care: a focus group study. (2010) (25)
Problems in the assessment of psychosomatic conditions in Social Security benefits and related commercial schemes. (1995) (24)
Pharmacokinetics of 14C CDP-choline. (1983) (24)
An assessment of S-carboxymethylcysteine in the treatment of chronic bronchitis. (1974) (21)
CDP-choline: repeated oral dose tolerance studies in adult healthy volunteers. (1983) (20)
Relationship between nocturnal plasma oestrogen concentration and free plasma tryptophan in perimenopausal women. (1977) (15)
Proceedings: Plasma L-tryptophan concentrations in chronic rheumatic diseases and the effects of some antirheumatic drugs on the binding of the amino-acid to plasma proteins in vivo and in vitro. (1974) (13)
Simultaneous pharmacokinetics of benorylate in plasma and synovial fluid of patients with rheumatoid arthritis. (1975) (12)
The return to work discussion: a qualitative study of the line manager conversation about return to work and the development of an educational programme. (2012) (12)
Letter: Natural oestrogen replacement therapy and blood clotting. (1976) (11)
Long-term monitoring of the effects of thymoxamine hydrochloride tablets in the management of patients with Raynaud's disease. (1982) (11)
A Double‐blind Crossover Trial comparing a New Antirheumatic Agent Alclofenac with Phenylbutazone in Chronic Rheumatic Disorders (1972) (11)
The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis. (1975) (11)
Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor. (1974) (11)
Disability assessment medicine (1999) (10)
Evaluation of tolmetin in the treatment of active chronic rheumatoid arthritis open and controlled double-blind studies (1976) (10)
Hexopal in Raynaud's Disease (1979) (10)
Common Health Problems, Yellow Flags and Functioning in a Community Setting (2010) (10)
Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric. (1978) (9)
Conditionality in context: Incapacity benefit and social deprivation in Merthyr Tydfil (2006) (8)
Measuring harm and informing quality improvement in the Welsh NHS: the longitudinal Welsh national adverse events study (2017) (8)
Clinical studies on alclofenac in the treatment of rheumatic diseases: a drug in question. (1975) (8)
Oestrogen replacement therapy and blood clotting (1977) (7)
Sulpiride in Depressive Illness (1981) (7)
Treatment of rheumatoid arthritis with tolmetin: a comparison with alclofenac. (1976) (7)
Alclofenac in Rheumatoid Arthritis: an evaluation of its Anti‐inflammatory and Analgesic Effects (1973) (7)
Health, work, and inactivity: current context and developing solutions - a UK perspective [Abstract] (2005) (6)
Support, rehabilitation, and interventions in restoring fitness for work (2013) (6)
Mefenamic Acid and Diclofenac Sodium in Osteoarthritis of the Weight Bearing Joints: A Double Blind Comparison (1985) (5)
A review of possible mechanisms of action of the antirheumatic drug, alclofenac. (1975) (5)
The influence of diclofenac sodium (Voltarol) on free, protein-bound and total plasma L-tryptophan in adult healthy male subjects. (1979) (5)
Beliefs: clinical and vocational interventions; tackling psychological and social determinants of illness and disability (2006) (4)
Metabolic and pharmacokinetic studies on Bamifylline. A review. (1978) (3)
Toxicity of benorylate. (1973) (3)
Clinical-evaluation of carbocisteine (mucolex) in the treatment of patients with chronic-bronchitis - a double-blind trial with placebo control (1985) (3)
Abstracts of Free Communications (2013) (3)
Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations. (1978) (3)
[Treatment of morning migraine. Clinical and biokinetic correlation of programmed-release dihydroergotamine]. (1984) (3)
Sickness certification system in the United Kingdom (2004) (3)
Government's expert group has reached consensus on prognosis of chronic fatigue syndrome (1996) (3)
On the treatment of migraine. Pharmacokinetic-pharmacodynamic relationships for a programmed release formulation of dihydroergotamine administered orally in the human (1983) (2)
Clinical therapeutic evaluation of methylcysteine hydrochloride in patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control. (1978) (2)
Levy on the self-employed (1977) (2)
The disability handbook : a handbook on the care needs and mobility requirements likely to arise from various disabilities and chronic illnesses (1998) (2)
Certifying incapacity for work (1995) (2)
Disability and Social Policy in Britain Since 1750: A History of Exclusion. Anne Borsay. Published by Palgrave Macmillan, 2005. ISBN 0-333-91255-1. 306 pp. Price: £16.99. (2006) (1)
Response to: managing black when in the red, challenges for general practice. (2012) (1)
Evaluation of tolmetin in the treatment of arthritis: open and controlled double-blind studies. (1976) (1)
A double-blind comparison ofAlclofenac andaspirin in rheumatoid arthritis, andeffects oftherapy on serum immunoglobulins andrheumatoid factor (1974) (1)
Administration of state benefits (1996) (1)
Testicular cancer in fire fighters (2008) (1)
Physicochemical characteristics and biological-activity of an anti-inflammatory substance in human plasma [Abstract] (1975) (1)
Benefits Agency always holds consent before approaching healthcare professionals for information (1997) (0)
Common health problems in the general population: a bio-psychosocial approach [Abstract] (2007) (0)
The kinetics of intradermal radioisotope clearance and relationships to nutrient blood-flow, skin thermal clearance and total fingertip flow (1983) (0)
Bronchiolitis Obliterans and food flavouring agents. Report by the Industrial Injuries Advisory Councilin accordance with Section 171 of the Social SecurityAdministration Act 1992 reviewing prescriptionfor Bronchiolitis Obliterans and food flavouringagents (2008) (0)
Plan for General Practice (1965) (0)
The Clinical Evaluation of Specific Drugs: (e.g. Penicillamine, Levamisole etc.) in the Treatment of Rheumatoid Arthritis and Allied Disorders (1977) (0)
The measurement of harm in inpatient settings: an overview (2017) (0)
Clinical evaluation of specific drugs (eg penicillamine, levamisole etc) in treatment of rheumatoid-arthritis and allied disorders [Abstract] (1977) (0)
Examples of Harm2 adverse events falling into the NCC MERP’s Categorizing Medication Errors Index in the randomly selected deceased patient reviews (2017) (0)
Binding characteristics and molecular-conformation of serum-albumin in rheumatic diseases and their significance in assessments of disease activity and drug response [Abstract] (1975) (0)
New development of an existing approach to health in Wales (2013) (0)
Comparison of D-penicillamine, gold and non-steroidal antirheumatic drugs in extended treatment of rheumatoid-arthritis [Abstract] (1975) (0)
The implementation of a harm surveillance system using the Harm2 tool (2017) (0)
Toxicity of benorylate. (1973) (0)
Alclofenac in long-term treatment of rheumatoid-arthritis (RA) [Abstract] (1975) (0)
CHANGING THE CULTURE ABOUT WOR K, HEALTH, AND ECONOMIC INACTIVITY : THE PIVOTAL ROLE OF ALL HEALTHCARE PROFESSIONALS (2008) (0)
Administration of state benefits [Letter] (1996) (0)
Clinical studies on alclofenac - critical review of a novel compound for treatment of rheumatic diseases [Abstract] (1975) (0)
Ruminations from the Bevan Commission (2018) (0)
Treatment of Rheumatoid Arthritis. (1950) (0)
Description of ME in disability handbook (1993) (0)

This paper list is powered by the following services:

Other Resources About Mansel Aylward

en.wikipedia.org

What Schools Are Affiliated With Mansel Aylward?

Mansel Aylward is affiliated with the following schools:

Cardiff University